Aintree – Cost-Effectiveness of Ambulatory Oxygen in Improving Quality of Life in Fibrotic Lung Disease: Preliminary Evidence from the AmbOx Trial

Author: Whitty JA, Rankin J, Visca D, Tsipouri V, Mori L, Spencer L, Adamali H, Maher TM, Hopkinson NS, Birring SS, Farquhar M, Wells AU, Sestini P, Renzoni EA.

Source: Eur Respir J. 2019 Nov 7. pii: 1901157.

doi: 10.1183/13993003.01157-2019. [Epub ahead of print] No abstract available.

PMID: 31699838 [PubMed – as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *